// App-Quantinova.ai

: Case Series Non-Lipid Plaque Formation as the Mechanism for Ponatinib-Induced Vascular Toxicity Using Operator-Assisted Virtual Histology Optical Coherence Tomography

Researchers

Presenter

  • Moez Aziz

Principal Investigators

  • Efstratios Koutroumpakis

  • Anita M Deswal

  • Dominique Monlezun

  • Nicole Thomason

  • Junichi Abe

  • Prince Otchere

  • Nicolas L Palaskas

  • Elias Jabbour

  • Peter Kim

  • Juan Lopez-Mattei

  • Mehmet Cilingiroglu

  • Konstantinos Marmagkiolis

  • Marc D Feldman

  • Cezar Iliescu

Medical Centers

  • 1.MD Anderson Cancer Center, Houston, TX

  • Univ of Texas MD Anderson Can, Houston, TX

  • UNIV TX HTLH SCI CTR, San Antonio, TX

  • UT MD ANDERSON CANCER CENTER, Houston, TX

  • Arkansas Heart Hosp, Little Rock, AR

  • 1.MD Anderson Cancer Center, Houston, TX

  • Lee Health Heart and Vascular Inst., Fort Myers, FL

  • Tampa heart, Tampa, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute lymphoblastic leukemia

  • Congestive heart failure

  • Coronary Artery Disease

  • Hypertension

  • Diabetes

  • Angina

Biomarkers

  • Breakpoint Cluster Region

  • Ph chromosome

Drug/Treatment

  • Ponatinib

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A